Men diagnosed at this hospital trust can access the following services (updated 2022):

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Whole body MRI
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Genetic counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	433	880
Performance Status recorded	46%	53%
PSA completed	50%	41%
Gleason Score completed	81%	83%
TNM completed	81%	73%

	Specialist MDT	National
No. of men with disease status determined	778	31258
Percentage of men diagnosed with metastatic disease	21%	19%

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	75	3680
Percentage of men with low-risk localised disease receiving radical treatment	0%	9%
No. of men diagnosed with locally advanced disease	264	11503
Percentage of men diagnosed with locally advanced disease receiving radical treatment	70%	69%

	Treatment Centre
No. of men who received radical prostatectomy (Apr 2021 - Mar 2022)	151
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	21%
No. of men who received radical prostatectomy (Sep 2019 - August 2020)	148
Adjusted percentage of men experiencing at least one GU complication (%)	12%
No. of men who received radical radiotherapy (Sep 2019 - August 2020)	272
Adjusted percentage of men experiencing at least one GI complication (%)	5%